≡ Menu ≡ Menu

Zantac Pancreatic Adenocarcinoma Lawsuit: Were You or a Loved One Diagnosed With Adenocarcinoma of the Pancreas After Taking Zantac (Ranitidine)?

Zantac Pancreatic Adenocarcinoma lawsuit cases settlement claims Ranitidine pancreas

If you or a loved one were diagnosed with pancreatic adenocarcinoma or adenocarcinoma of the pancreas after taking Zantac, you may be entitled to recover compensation from a Zantac pancreatic adenocarcinoma lawsuit case or settlement claim.

A team of heartburn drug injury lawyers and class action attorneys is investigating potential lawsuit and settlement cases of individuals who claim to have been diagnosed with pancreatic adenocarcinoma after taking Zantac or Ranitidine for heartburn.

An adenocarcinoma of the pancreas is a type of exocrine pancreas cancer that begins in the cells lining the pancreatic duct (the cells that produce enzymes to assist in digestion). Approximately 60–70 percent of pancreatic adenocarcinomas are located in the head of the pancreas, while about 10-15 percent are found in the tail of the pancreas, and about 5-10 percent are loctaed in the body of the pancreas.

Pancreatic adenocarcinomas are the most common type of pancreatic cancer, accounting for about 90% of all pancreatic cancer cases. Pancreatic adenocarcinoma is considered a highly aggressive malignancy associated with very poor clinical prognosis (due in part to its typically late presentation of symptoms and resistance to various forms of traditional treatments, such as chemotherapy and radiation treatment). 

Zantac Pancreatic Adenocarcinoma Lawsuit Cases

Zantac pancreatic adenocarcinoma lawsuit and settlement cases potentially being investigated include claims of individuals who took ranitidine or Zantac that was recalled and suffered serious injuries, side-effects or complications including, among others:

  • Pancreatic adenocarcinoma
  • Pancreatic ductal adenocarcinoma (PDAC)
  • Ductal carcinoma of the pancreas
  • Cancer of the pancreatic duct
  • Primary malignant neoplasm of pancreatic duct
  • Infiltrating ductal adenocarcinoma of the pancreas 

If you or a loved one took Zantac or Ranitidine and suffered from pancreatic adenocarcinoma, you may be entitled to compensation from a Zantac pancreatic adenocarcinoma lawsuit or settlement. Contact a drug injury lawyer to request a free case review.

*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.

**The listing of a company (e.g., Sandoz, Sanofi, Apotex, Perrigo, Lannett or Novitium) or product (e.g., Zantac or Ranitidine) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.

***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.

Fill out the form on the right for a free attorney review.